"We are looking to improve human performance, extend life, prevent disease and make all people wealthier by developing a decentralized ecosystem for exchange and utilization of human life data using the latest advances in blockchain and artificial intelligence"
Longenesis life data Escrow and ecosystem powered by the next-generation artificial intelligence and blockchain technologies

Have questions? Subscribe us on Telegram
January 2017
BitFury and Insilico Medicine meet
at the JP Morgan Conference
in San Francisco to discuss AI & Blockchain
for Healthcare
August 2017
The Insilico Medicine has formed
a partnership with the Bitfury Group
  • Leader in Artificial Intelligence for Drug Discovery, Biomarker Development and Aging Research
  • Attracted over $12 million in venture funding
  • NVIDIA's top 5 AI Companies for Social Impact
  • Over 200 research collaborators worldwide
  • Deals with big pharma companies
  • Nutraceuticals sold on the market with human data tracking system
  • Over 40 peer-reviewed research publications
  • Top SAB including a Nobel laureate
  • Executed Projects: Young.AI, Embryonic.AI,, Chemistry.AI,
  • Leader in blockchain platforms and #2 largest Bitcoin miner in the world
  • Proprietary semiconductor and cooling technologies
  • Sophisticated Exonum bloсkchain platform.
  • Attracted over $250 million in venture funding
  • Over $250 million in annual revenues
  • Over 300 developers and staff in 16 countries
  • Large government projects: Georgia, Ukraine, UK, Kazakhstan, Africa
  • Top strategy, legal and business development talent including Jamie Smith, former White House deputy secretary and many others Amsterdam, Netherlands
The company is planning to employ a team of over 30 scientists and business development professionals worldwide

    Two best teams are coming together to form
    Blue Chip AI & Blockchain Company

    • NVIDIA's top 5 AI Companies for Social Impact in 2017
    • Leading Bitcoin Blockchain infrastructure provider and 2nd largest Bitcoin miner in the world
    • Top Global 100 AI companies in 2018 according to CB Insights
    • Solving two of the humanity's most pressing problems: ownership of personal data and longevity using AI and blockchain
      • Advisory includes a former SEC Commissioner, former chief scientist of the Human Genome Project
        • Over $2, 000 000 allocated for initial legal fees to make every effort to ensure that the token generating event is compliant with the most regulatory requirements
          • Token generating event launch with the minimal viable product (data can be exchanged for tokens)
          Just by submitting information and regularly contributing data to Longenesis, users will be generating currency. This on top of traditional mining of blocks will create a healthy circulation of life data.
          Everybody can be a miner
          Use Case
          Our Goal is to build a revolutionary platform that delivers the future of Medicine and Data Analytics through AI-Blockchain integration
          By building and launching this platform on blockchain technology, we can assure our users that their files are private and secure. Users can store and track their medical data to gain insight into their health like never before.
          Securely store data and track your health
          Utilizing smart contracts to give the buyer and seller a direct line of communication in a secure manner. Buyers can send data requests to Sellers without having to go through a human intermediary so the process can be streamlined. This allows buyers and sellers to communicate directly in a secure setting.
          Direct interaction without third parties
          Longenesis Data Escrow will be able to provide new insights in the fields of Healthcare R&D. It will provide analysis and recommendations to Pharmaceutical companies to help develop new drugs.
          Healthcare Development

          Alpha version

          How it works

          Provide data, use the platform as storage and as services for personal health improvements (by utilizing platform health tracking functions, by buying customized apps).
          Organizations, who provide data and feed the system, and use the platform services for storage.

          Buy data (Business). Pharma and medical research companies are considered buyers of anonymous medical data.
          Buy data for the creation of special plug-and-play services for Longenesis platform (ex. highly-personalized apps for health, sport, dating, fun, diet, etc).
          36th Annual Healthcare
          8-11 January 2018
          Conference, New York, USA
          14–16 May 2018
          Conference, San Francisco, USA
          Consensus 2018
          Singularity Exponential Medicine 2017
          South Korea
          San Diego, USA
          The Global Leaders Forum
          Alex Zhavoronkov, CEO, Insilico Medicine

          Valery Vavilov, Founder and CEO, Director of the Board, Bitfury
          © 2018 All Rights Reserved. Longenesis Ltd.